Kimia Farma
Kimia Farma, officially known as PT Kimia Farma Tbk, is a prominent player in Indonesia's pharmaceutical industry, headquartered in Jakarta. Established in 1817, it stands as one of the oldest pharmaceutical companies in the country, with a rich history marked by significant milestones in healthcare innovation and accessibility. The company operates extensively across Indonesia, focusing on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and herbal remedies. Kimia Farma is renowned for its commitment to quality and affordability, making healthcare accessible to a broader population. With a strong market position, Kimia Farma has achieved notable recognition for its extensive network of pharmacies and healthcare services, contributing significantly to Indonesia's healthcare landscape. Its dedication to research and development further solidifies its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Kimia Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kimia Farma's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kimia Farma's reported carbon emissions
In 2022, Kimia Farma reported total carbon emissions of approximately 509,246,840 kg CO2e, all of which fall under Scope 1 emissions, indicating direct emissions from owned or controlled sources. There were no reported emissions for Scope 2 or Scope 3, which typically encompass indirect emissions from purchased electricity and other value chain activities, respectively. Comparatively, in 2021, the company’s emissions were significantly higher at about 1,085,841,150 kg CO2e, also entirely from Scope 1. This represents a substantial reduction of approximately 576,594,310 kg CO2e year-on-year, showcasing a strong commitment to lowering their carbon footprint. Despite these reductions, Kimia Farma has not set specific science-based targets (SBTi) or documented climate pledges, indicating a potential area for future commitment. The emissions data is cascaded from its parent company, PT Kimia Farma Tbk, reflecting the broader corporate family’s performance in emissions reporting. Overall, while Kimia Farma has made notable strides in reducing its carbon emissions, the absence of comprehensive climate commitments or targets suggests opportunities for further engagement in climate action initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 193,144,650 | 0,000,000,000 | 000,000,000 |
| Scope 2 | - | - | - |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kimia Farma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
